







Robin Smith is the co-founder CEO of ORIG3N, a regenerative medical company that has crowdsourced blood samples to create the world’s biggest and most
The Real Story Of How I Sold Two Startups, The Chaos Afterwards, And What’s Next – The Health Care Blog
Today we’re starting a series of more personal stories, looking at what makes interesting people in health care tick. Alex Carmichael is a rare multiple time CEO in health technology, and she has a very interesting tale to tell–Matthew Holt

No title
Two genetic programs have been discovered that turn stem cells into blood. The method, which mirrors the way blood is produced in the body, allows

Sam Altman's Brain Chip Venture Is Mulling Gene Therapy Approach - Slashdot
Sam Altman's brain-chip venture is exploring the idea of genetically altering brain cells to make better implants. "The company, which has been referred to as Merge Labs, is looking at an approach involving gene therapy that would modify brain cells," reports Bloomberg. "In addition, an ultrasound d...

Implantable 3D-printed organs could be coming sooner than you think | TechCrunch
At MBC Biolabs, an incubator for biotech startups in San Francisco's Dogpatch neighborhood, a team of scientists and interns working for the small startup

$250 million, 300 scientists and 40 labs: Sean Parker’s revolutionary project to ‘solve’ cancer
The collaboration, which will be formally announced Wednesday, focuses on immunotherapy -- an area of research that many believe represents the future of cancer treatment.

Biotech company Regeneron to buy bankrupt 23andMe for $256M
Regeneron will use trove of 23andMe genetic data to develop medical advances.

We live in a golden age of biology. So why are people still dying from disease? Because discovery and development move slower than they should. Today, we’re partnering with Incyte to change… | Samuel G. Rodriques | 491 comments
We live in a golden age of biology. So why are people still dying from disease? Because discovery and development move slower than they should. Today, we’re partnering with Incyte to change that. Kosmos is now the first agent that can compress months of drug development into weeks, from the earliest stages of scientific discovery through to FDA approval. Incyte will be the first company to deploy it across their pipeline. Work that used to take a team of scientists months now happens in weeks. Patients can't wait, and neither can we. | 491 comments on LinkedIn
Ramez Naam on Twitter / X
There was a site years ago called CureTogether where patients could share information in a structured way on their disease, regimen, and progress, working towards a sort of bottoms-up clinical trial. 23andMe acquired them and it seems to be mostly dead.— Ramez Naam (@ramez) September 14, 2025
Researchers 3D-Print Heart From Human Patient's Cells - Slashdot
Researchers have 3D-printed a heart using a patient's cells, providing hope that the technique could be used to heal hearts or engineer new ones for transplants. "This is the first time anyone anywhere has successfully engineered and printed an entire heart replete with cells, blood vessels, ventric...

Why I injected myself with an untested gene therapy
The biohacker movement wants to cure disease without the help of government or big companies

How Open Protocols Are a Key Part of Regenerative Technology - Identity Woman
TLDR Infographic: What does it actually take for digital technology to be regenerative? The question matters because most of the digital tools being adopted right now in bioregional movements, community organizing, regenerative finance, and the broader systemic-change ecosystem are being chosen without anyone asking it carefully. The slide decks are beautiful. The intentions are sincere. […]

They’re Alive! Watch These Mini 3D Printed Organs Beat Just Like Hearts
There’s something almost alchemical going on at the Wake Forest Institute for Regenerative Medicine. Scientists there have genetically transformed skin cells into heart cells and used them to 3D print...


CIA’s Venture Capital Arm Is Funding Skin Care Products That Collect DNA
A company with an innovative line of cosmetic products caught the attention of Oprah’s lifestyle magazine and beauty bloggers. Now the CIA is involved, too.

Now We Can Grow Kidney Structures from Stem Cells
Two research teams in the last two months have published studies on kidney structures grown from stem cells, which might be a step toward personalized

Researchers published in NEJM about using OpenAI’s o3 DeepResearch to discover strong leads in 18 previously unsolved rare diseases o3 produced *explanations* of old lab results (not diagnoses), which researchers vetted and took to the lab AI is not just a black box openai.com/index/diagnose-rare-childhood…
Using AI to help physicians diagnose rare genetic diseases affecting children
openai.com